BioSpace News Archive

SAN RAFAEL, Calif., /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced the debut of the Broadway-style ‘Hemophilia: The Musical,’ a first-of-its-kind theatrical production featuring 25 students affected by a bleeding disorder.

“I desired a means to help people,” said an inventor from Orange, N.J. “This inspired me to develop a device to monitor vital signs to alert someone of an injury or illness.”

The Dallas Morning News reported in September that the Texas School Board is considering removing Helen Keller from its Grade 3 social studies curriculum.

A white paper written by Crohn’s & Colitis Foundation scientific advisors and staff examining the clinical, scientific, and regulatory landscape as it pertains to the use of medical cannabis in the treatment of Crohn’s disease and ulcerative colitis was recently published online by Inflammatory Bowel Diseases.

Metrics Contract Services is pleased to announce successful qualification of two commercial bottling lines for serialization at its new US$80 million oral solid dose commercial manufacturing site in Greenville, North Carolina, USA.

Urovant Sciences Ltd. today reported financial results for the three and six months ended September 30, 2018 and announced corporate updates.

Valens GroWorks Corp. is pleased to announce that it has received its updated standard processing and standard cultivation license on November 9th, 2018.

- Data support ongoing evaluation of Synthetic BioticTM SYNB1020 for the potential treatment of hyperammonemia -

Titan Medical Inc. announces financial results for the three and nine months ended September 30, 2018.

Angion Biomedica and Sinovant Sciences today announced a collaboration and license agreement for BB3, Angion’s investigational small molecule mimetic of hepatocyte growth factor (HGF), in the People’s Republic of China, Hong Kong, Macau, and Taiwan (Greater China).